Effect of cortisone treatment on the active transport of calcium by the small intestine

D V Kimberg, R D Baerg, E Gershon, R T Graudusius, D V Kimberg, R D Baerg, E Gershon, R T Graudusius

Abstract

It is generally recognized that glucocorticoid administration may diminish calcium absorption in vivo as well as the active transport of calcium by the intestine in vitro. Recent studies by others have emphasized the possibility of an alteration in the metabolism of vitamin D to 25-hydroxycholecalciferol in accounting for the steroid effects on calcium absorption. The results obtained in the present studies fail to support this hypothesis. The present studies confirm that the administration of cortisone or other glucocorticoids to the rat interferes with the active transport of calcium by duodenal gut sacs in vitro. This abnormality is not due to an alteration in the permeability of the intestine to calcium, and it cannot be corrected by the administration of either massive doses of vitamin D(2) or modest doses of 25-hydroxycholecalciferol. Experiments concerned with the effects of cortisone on the level of the vitamin D-dependent duodenal calcium-binding protein, the amount of bioassayable vitamin D activity in the mucosa, and the distribution and metabolism of (3)H-vitamin D(3), did not provide evidence in favor of a harmone-related defect in either the localization of vitamin D or its metabolism to 25-hydroxycholecalciferol. Alterations in the transport of iron and D-galactose, not dependent on vitamin D, suggest that cortisone treatment may be responsible for more than a simple antagonism to the effects of vitamin D. The results of the present studies indicate that cortisone administration affects the cellular mechanisms mediating calcium transport in a manner that is opposite to the effects of vitamin D, but seems to be independent of any direct interaction with the parent vitamin or its metabolites. If a disorder in vitamin D metabolism is at all involved, it is at a step subsequent to 25-hydroxylation.

References

    1. J Lipid Res. 1966 Nov;7(6):739-44
    1. Ann Intern Med. 1958 Apr;48(4):765-73
    1. Fed Proc. 1969 Sep-Oct;28(5):1678-89
    1. Am J Physiol. 1960 Aug;199:265-71
    1. Am J Med. 1964 Apr;36:500-13
    1. Acta Physiol Scand. 1951 Aug 25;23(2-3):110-27
    1. J Biol Chem. 1968 Jul 25;243(14):3987-93
    1. J Clin Endocrinol Metab. 1954 Jun;14(6):653-60
    1. Am J Clin Nutr. 1969 Apr;22(4):431-6
    1. Lancet. 1956 Jun 16;270(6929):925-31
    1. Proc Soc Exp Biol Med. 1961 Mar;106:664-6
    1. Am J Physiol. 1966 Nov;211(5):1131-6
    1. Science. 1969 Jul 25;165(3891):405-7
    1. Am J Physiol. 1969 Oct;217(4):1144-8
    1. J Am Med Assoc. 1954 Jan 2;154(1):42-4
    1. J Physiol. 1954 Jan;123(1):116-25
    1. Acta Paediatr. 1955 Nov;44(6):559-78
    1. Am J Physiol. 1960 Feb;198:275-9
    1. Science. 1966 May 6;152(3723):791-3
    1. Lancet. 1954 Oct 9;267(6841):720-4
    1. Endocrinol Jpn. 1966 Dec;13(4):409-15
    1. J Clin Invest. 1969 Nov;48(11):2032-7
    1. Am J Physiol. 1959 Feb;196(2):357-62
    1. Proc Natl Acad Sci U S A. 1968 Dec;61(4):1503-6
    1. Can J Biochem Physiol. 1959 Aug;37(8):911-7
    1. Am J Physiol. 1961 Jun;200:1256-62
    1. Proc Soc Exp Biol Med. 1966 Oct;123(1):212-3
    1. Acta Endocrinol (Copenh). 1967 Feb;54(2):380-4
    1. Nature. 1969 May 3;222(5192):482-3
    1. J Clin Endocrinol Metab. 1968 Sep;28(9):1341-6
    1. Science. 1969 Mar 28;163(3874):1450-1
    1. Biochemistry. 1968 Oct;7(10):3317-22
    1. Am J Physiol. 1960 Feb;198:263-8
    1. Arch Intern Med. 1964 Sep;114:434-8
    1. Am J Physiol. 1961 Jun;200:1263-71
    1. Arch Biochem Biophys. 1967 Mar;119(1):536-40
    1. Metabolism. 1962 Jul;11:716-26
    1. Am J Physiol. 1962 Sep;203:506-12

Source: PubMed

3
Sottoscrivi